Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

relugolix MeSH Supplementary Concept Data 2026


MeSH Supplementary
relugolix
Unique ID
C561634
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C561634
Entry Term(s)
1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno(2,3-d)pyrimidin-6-yl)phenyl)-3-methoxyurea
TAK 385
TAK-385
TAK385
orgovyx
Pharm Action
Androgen Antagonists
Registry Numbers
0
Heading Mapped to
*Phenylurea Compounds
*Pyrimidinones
Frequency
48
Note
structure in first source
Source
J Med Chem 2011 Jul 28;54(14):4998-5012
Indexing Information
Receptors, LHRH
Date Introduced
2011/10/09
Last Updated
2021/07/20
relugolix Preferred
TAK 385 Narrower
1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno(2,3-d)pyrimidin-6-yl)phenyl)-3-methoxyurea Broader
orgovyx Narrower
page delivered in 0.006s